Pain Relief Devices: TENS, Neuromodulation & Wearable Tech in 2026
Technology

Pain Relief Devices: TENS, Neuromodulation & Wearable Tech in 2026

James Chen, RD

James Chen, RD

James Chen is a registered dietitian specializing in anti-in

Published 2026-04-03Updated 2026-04-07

Pain management is increasingly influenced by bioelectronics, AI, and digital health. Neuromodulation — altering nerve activity through targeted stimulation — can be useful for selected pain conditions, though device choice and patient selection matter.

How Neuromodulation Works

By delivering electrical, magnetic, or sensory stimulation to specific nerve pathways, these devices may interrupt pain signal transmission, trigger endogenous pain-relieving mechanisms, or influence pain-processing networks.

TENS: The Accessible Foundation

Transcutaneous Electrical Nerve Stimulation (TENS) devices deliver low-voltage electrical impulses through skin electrodes. They are often explained through the gate-control theory of pain, in which stimulation of certain nerve fibers can reduce the perception of pain signals. While not a cure, TENS may provide short-term relief for some people and is widely accessible without prescription.

AI-Powered Spinal Cord Stimulation

Traditional spinal cord stimulation (SCS) uses implanted epidural electrodes that are programmed and adjusted over time. Newer systems, including Nevro's HFX AdaptivAI platform, are using data-driven personalization to refine stimulation settings.

What Makes It Different These systems aim to make SCS less static by using patient-reported outcomes, device-use patterns, and programming data to personalize treatment. For people considering implanted stimulation, benefits, surgical risks, trial response, battery needs, and follow-up requirements all matter.

Smart Power Management Features like dynamic pulse dosing may help tailor stimulation and battery use. Recharge frequency and outcomes vary by device, settings, and patient use.

FDA-Cleared Migraine Wearables

For migraine sufferers, several non-invasive devices are available or prescribed for selected patients:

CEFALY (External Trigeminal Nerve Stimulation) This forehead-worn device delivers micro-electrical impulses to the supraorbital branch of the trigeminal nerve. It includes acute and preventive modes. Small neuroimaging studies suggest external trigeminal nerve stimulation may influence brain regions involved in migraine processing, but this should not be read as a guaranteed structural brain change for every user.

gammaCore (Non-Invasive Vagus Nerve Stimulation) This device delivers gentle electrical pulses to the vagus nerve in the neck, modulating parasympathetic tone to abort acute migraine and cluster headache attacks — all without drug-like side effects.

SAVI Dual (Transcranial Magnetic Stimulation) Using single-pulse transcranial magnetic stimulation (sTMS), this device disrupts cortical spreading depression — the wave of neuronal activity believed to trigger migraine aura and headache.

Audio-Visual Stimulation: The Frontier

The Sana Device represents an entirely novel approach: an externally worn mask delivering coordinated pulses of light through closed eyelids, synchronized with specific audio frequencies. This audio-visual entrainment (AVE) targets the primary visual and auditory cortices to encourage global brainwave alignment at specific frequencies (often 40 Hz gamma-band).

Clinical evidence for audio-visual stimulation is still developing. FDA clearance status, indication, and the specific diagnosis being treated should be checked before relying on any device.

Biomechanical Smart Devices

The AposHealth system takes a different approach: custom-calibrated convex rubber elements attached to shoe soles create controlled instability during walking. The goal is gait retraining and load redistribution for knee osteoarthritis. Some clinical and claims-data studies report improved outcomes and lower healthcare utilization, but cost results may not generalize to every patient or health system.

What to Consider

When evaluating wearable pain devices, consider:
- FDA clearance or approval status — helps confirm that the device has been reviewed for a specific use
- Your specific pain mechanism — TENS for nociceptive, neuromodulation for neuropathic, AVE for centralized
- Cost vs. likely benefit — coverage, out-of-pocket cost, and maintenance vary widely
- Your physician's guidance — these work best as part of a comprehensive plan

The Bottom Line

These technologies can be useful tools, especially when matched to the right diagnosis and care plan. They are not universal replacements for medication, physical therapy, procedures, or medical evaluation.

Sources - [FDA medical device approvals database](https://www.fda.gov/medical-devices/recently-approved-devices) - [External trigeminal nerve stimulation and migraine FDG-PET study](https://pmc.ncbi.nlm.nih.gov/articles/PMC5560481/) - [AposHealth knee osteoarthritis claims analysis](https://pmc.ncbi.nlm.nih.gov/articles/PMC11102045/)

TENSneuromodulationwearable devicesAImigraine devicesspinal cord stimulation

Keep Exploring